(R)- and (S)-3-fluorothalidomides: Isosteric analogues of thalidomide

Organic Letters

Volumn 1, Issue 10, 1999, Pages 1571-1573

  Takeuchi, Yoshio ^a   Shiragami, Tomoki ^a   Kimura, Kenichi ^a   Suzuki, Emiko ^a   Shibata, Norio ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001093384     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol9902172     Document Type: Article

References (45)

1. (a) McBride, W. G. Lancet 1961, 2, 1358.
2. (b) Lenz, W. Lancet 1962, 1, 45.
3. (a) Gunzler, V. Drug Safety 1992, 7, 116.
4. (b) Sheskin, J. Clin. Pharmacol. Ther. 1965, 6, 303.
5. (c) Makonkawkeyoon, S.; Limson-Pobre, R. N. R.; Moreira, A. L.; Schauf, V.; Kaplan, G. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 5974.
6. (a) Randall, T. J. Am. Med. Assoc. 1990, 263, 1467.
7. (b) Skolnick, A. J. Am. Med. Assoc. 1990, 263, 1468.
8. (c) Randall, T. J. Am. Med. Assoc. 1990, 263, 1474.
9. (d) Muller, G. W. Chemtech 1997, 27, 21.
10. Chem. Ind. 1998, 591.
11. (a) Wintersk, W.; Frankus, E. Lancet 1992, 339, 365.
12. (b) Eriksson, T.; Bjorkman, S.; Roth, B.; Fyge, A.; Hoglund, P. Chirality 1996, 7, 44.
13. (c) Shealy, Y. E.; Opliger, C. E.; Montgomery, J. A. Chem. Ind. 1965, 1030.
14. (a) Wnendt, S.; Finkam, M.; Winter, W.; Ossing, J.; Rabbe, G.; Zwingenberger, K. Chirality 1996, 8, 390.
15. (b) Knoche, B.; Blaschke, G. J. Chromatogr. 1994, 2, 183.
16. (c) Winter, W.; Frankus, E. Lancet 1992, 339, 365.
17. (d) Nishimura, K.; Hashimoto, Y.; Iwasaki, S.; Biochem. Biophys. Res. Commun. 1994, 199, 455.
18. Blaschke, G.; Graute, W. F. Liebigs Ann. Chem. 1987, 647.
19. Beuch, H. P.; Omlor, G.; Knabe, J. Arzneim. Forsch. 1990, 40, 32.
20. (a) Nishimura, K.; Hashimoto, Y.; Iwasaki, S. Chem. Pharm. Bull. 1994, 42, 1157.
21. (b) Miyachi, H.; Azuma, A.; Hiroki, E.; Iwasaki, S.; Kobayashi, Y.; Hashimoto, Y. Biochem. Biophys. Res. Comm. 1996, 226, 439.
22. For example; (a) Muller, G. W.; Chen, R.; Huang, S.-Y.; Corral, L. G.; Wong, L. M.; Patterson, R. T.; Chen, Y.; Kaplan, G.; Stirling, D. I. Bioorg. Med. Chem. Lett. 1999, 9, 1625.
23. (b) Miyachi, H.; Azuma, A.; Ogasawara, A.; Uchimura, E.; Watanabe, N.; Kobayashi, Y.; Kato, F.; Kato, M.; Hashimoto, Y. J. Med. Chem. 1997, 40, 2858.
24. (c) Muller, G. W.; Corral, L. G.; Shire, M. G.; Wang, H.; Moreira, A.; Kaplan, G.; Stirling, D. I. J. Med. Chem. 1996, 39, 3238.
25. (d) Turk, B. E.; Jiang, H.; Liu, J. O. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 7552.
26. (e) Niwayama, S.; Turk, B. E.; Liu, J. O. J. Med. Chem. 1996, 39, 3044.
27. (f) Corral, L. G.; Muller, G. W.; Moreiram. A.; Chen, Y.; Wu, Mingdan; Stirling, D. I.; Kaplan, G. Mol. Med. 1996, 2, 506.
28. Fusso & Yakugaku; Kobayashi, Y., Kumadaki, I., Taguchi, T., Eds.; Hirokawa Publishing Co.: Tokyo, 1992.
29. (a) Biomedical Aspects of Fluorine Chemistry; Filler, R., Kobayashi, Y., Eds.; Kodansha/Elsevier Biomedical Press: Tokyo, Amsterdam-New York-Oxford, 1982.
30. (b) Biomedical Frontiers of Fluorine Chemistry (ACS Symposium Series 639); Ojima, I., McCarthy, J. R., Welch, J. T., Eds.; American Chemical Society: Washington, DC, 1996.
31. (a) Oklobdzija, M.; Comisso, G.; Decorte, E.; fajdiga, T.; Gratton, G.; Moimas, F.; Toso, R.; Sunjic, V. J. Heterocycl. Chem. 1983, 20, 1329.
32. (b) Belyaev, A. A.; Krasko, E. V. Synthesis 1991, 417.
33. (a) Gensler, W. J.; Ahmed, Q. A.; Leeding, M. V. J. Org. Chem. 1968, 33, 4279.
34. (b) Sharts, C. M.; Sheppard W. A. Org. React. 1974, 21, 125.
35. (c) Barth-Wehrenap, G. J. Inorg. Nucl. Chem. 1956, 2, 266.
36. (d) Leech, H. R. Chem. Ind. 1960, 242.
37. (e) Takeuchi, Y.; Nagata, K.; Koizumi, T. J. Org. Chem. 1989, 54, 3.
38. Attempted oxidation of 7 by the use of m-CPBA met failure.
39. (a) Sheehan, J. C.; Tulis, R. W. J. Org. Chem. 1974, 39, 2264.
40. (b) Tanaka, K.; Yoshifuji, S.; Nitta, Y. Chem. Pharm. Bull. 1987, 35, 364.
41. w = 0.044; temp = 23°C.
42. The assay was carried out in accordance with Kaplans' procedure (ref 19). See the Supporting Information.
43. (a) Sampaio, E. P.; Sarno, E. N.; Galilly, R.; Cohn, Z. A.; Kaplan, G. J. Exp. Med. 1991, 173, 699.
44. (b) Moreira, A. L.; Sampaio, E. P.; Zmuidzinas, A.; Frindt, P.; Smith, K. A.; Kaplan, G. J. Exp. Med. 1993, 177, 1675.
45. Since the difference in the activities between individual enantiomers may not be significant, biological activities in other assay systems are being determined.